Bone resorption inhibition/osteogenesis promotion compound

摘要

PCT No. PCT/JP94/00489 Sec. 371 Date Mar. 1, 1995 Sec. 102(e) Date Mar. 1, 1995 PCT Filed Mar. 25, 1994 PCT Pub. No. WO94/21667 PCT Pub. Date Sep. 29, 1994A compound represented by the following formula (I):X-Y-Z(I)[where Y is represented by the following formula (III): (III) (IV) (V) X is a monovalent group of a tetracycline type compound, and Z is a monovalent group of a steroid type compound such as estrogen]. The compound can concentrate on the bone tissue and has a bone resorption inhibition/ossification promotion functions.